NLS Pharmaceutics AG – NASDAQ:NLSPW

NLS Pharmaceutics AG stock price today

$0.02
+0.00
+75.44%
Financial Health
0
1
2
3
4
5
6
7
8
9

NLS Pharmaceutics AG stock price monthly change

-78.00%
month

NLS Pharmaceutics AG stock price quarterly change

-78.00%
quarter

NLS Pharmaceutics AG stock price yearly change

-88.99%
year

NLS Pharmaceutics AG key metrics

Market Cap
8.17M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-1.17
Revenue
N/A
EBITDA
-18.59M
Income
-20.03M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

NLS Pharmaceutics AG stock price history

NLS Pharmaceutics AG stock forecast

NLS Pharmaceutics AG financial statements

NLS Pharmaceutics AG (NASDAQ:NLSPW): Profit margin
Jun 2022 0 -8.64K
Dec 2022 0 -7.85M
Jun 2023 0 -7.61M
Dec 2023 0 -4.55M
NLS Pharmaceutics AG (NASDAQ:NLSPW): Debt to assets
Jun 2022 2058049 6.09M 296.37%
Dec 2022 9276643 5.99M 64.63%
Jun 2023 2270146 6.55M 288.83%
Dec 2023 1846641 10.68M 578.36%
NLS Pharmaceutics AG (NASDAQ:NLSPW): Cash Flow
Jun 2022 -7.66K 4.07M 3.58K
Dec 2022 -6.21M -7.59M 13.80M
Jun 2023 -7.29M 0 0
Dec 2023 -2.38M 0 1.63M

NLS Pharmaceutics AG other data

  • What's the price of NLS Pharmaceutics AG stock today?

    One share of NLS Pharmaceutics AG stock can currently be purchased for approximately $0.02.

  • When is NLS Pharmaceutics AG's next earnings date?

    Unfortunately, NLS Pharmaceutics AG's (NLSPW) next earnings date is currently unknown.

  • Does NLS Pharmaceutics AG pay dividends?

    No, NLS Pharmaceutics AG does not pay dividends.

  • How much money does NLS Pharmaceutics AG make?

    NLS Pharmaceutics AG has a market capitalization of 8.17M.

  • What is NLS Pharmaceutics AG's stock symbol?

    NLS Pharmaceutics AG is traded on the NASDAQ under the ticker symbol "NLSPW".

  • What is NLS Pharmaceutics AG's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of NLS Pharmaceutics AG?

    Shares of NLS Pharmaceutics AG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When NLS Pharmaceutics AG went public?

    NLS Pharmaceutics AG is publicly traded company for more then 4 years since IPO on 29 Jan 2021.

NLS Pharmaceutics AG company profile:

NLS Pharmaceutics AG

Exchange:

NASDAQ

Full time employees:

0

Industry:

Biotechnology

Sector:

Healthcare

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor to prevent rare sleep disorders; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist, improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. NLS Pharmaceutics AG was incorporated in 2015 and is based in Zurich, Switzerland.


,

CIK: 0001783036
ISIN: CH0573155204
: